DrugPatentWatch Database Preview
Sk Life Company Profile
» See Plans and Pricing
What is the competitive landscape for SK LIFE, and when can generic versions of SK LIFE drugs launch?
SK LIFE has one approved drug.
There is one US patent protecting SK LIFE drugs.
There are nineteen patent family members on SK LIFE drugs in eighteen countries.
Summary for Sk Life
| International Patents: | 19 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sk Life
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-002 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | Start Trial | Y | Start Trial | |||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-002 | Mar 10, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-001 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | Start Trial | Y | Start Trial | |||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-004 | Mar 10, 2020 | RX | Yes | No | Start Trial | Start Trial | |||||
| Sk Life | XCOPRI | cenobamate | TABLET;ORAL | 212839-005 | Mar 10, 2020 | RX | Yes | No | 7,598,279 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sk Life Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200709994 | Start Trial |
| Taiwan | 200722085 | Start Trial |
| Taiwan | I398249 | Start Trial |
| Spain | 2441765 | Start Trial |
| Malaysia | 148589 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
